5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.70▼ | 3.70▼ | 3.69▲ | 3.65▲ | 3.53▲ |
MA10 | 3.70▼ | 3.68▲ | 3.68▲ | 3.62▲ | 3.69▼ |
MA20 | 3.69▲ | 3.67▲ | 3.66▲ | 3.48▲ | 4.41▼ |
MA50 | 3.67▲ | 3.65▲ | 3.65▲ | 3.80▼ | 8.75▼ |
MA100 | 3.66▲ | 3.64▲ | 3.51▲ | 4.56▼ | 6.19▼ |
MA200 | 3.65▲ | 3.52▲ | 3.64▲ | 7.70▼ | 4.25▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | 0.004▲ | 0.002▲ | 0.060▲ | 0.159▲ |
RSI | 53.461▲ | 54.590▲ | 56.553▲ | 51.259▲ | 36.163▼ |
STOCH | 77.778 | 95.139▲ | 88.095▲ | 76.907 | 29.279 |
WILL %R | -25.000 | -2.500▲ | -7.143▲ | -15.294▲ | -70.968 |
CCI | 45.857 | 67.361 | 89.256 | 52.764 | -54.112 |
Sunday, July 03, 2022 07:42 PM
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
|
Thursday, June 30, 2022 04:07 AM
NEW YORK, June 30, 2022 (GLOBE NEWSWIRE) -- Kures Therapeutics, Inc (“Kures”), an atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”) company focused on ...
|
Thursday, June 30, 2022 04:01 AM
NEW YORK, June 30, 2022 (GLOBE NEWSWIRE) -- Kures Therapeutics, Inc (“Kures”), an atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”) company focused on developing treatment options to better ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
05/07/22 | 3.61 | 3.705 | 3.50 | 3.68 | 784,337 |
01/07/22 | 3.64 | 3.71 | 3.60 | 3.65 | 358,092 |
30/06/22 | 3.61 | 3.68 | 3.50 | 3.64 | 429,924 |
29/06/22 | 3.59 | 3.71 | 3.51 | 3.68 | 409,333 |
28/06/22 | 3.67 | 3.72 | 3.54 | 3.62 | 435,091 |
27/06/22 | 3.81 | 3.81 | 3.60 | 3.66 | 520,395 |
24/06/22 | 3.69 | 3.805 | 3.5721 | 3.79 | 685,427 |
23/06/22 | 3.55 | 3.65 | 3.455 | 3.65 | 341,044 |
22/06/22 | 3.28 | 3.60 | 3.28 | 3.50 | 992,754 |
21/06/22 | 3.36 | 3.4675 | 3.32 | 3.36 | 619,907 |
|
|
||||
|
|
||||
|
|